Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stereotaxis (STXS)
NYSE MKT:STXS
Holding STXS?
Track your performance easily
STXS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.40 - $3.29
Previous Close$1.85
Volume992.09K
Average Volume (3M)208.93K
Market Cap
$156.61M
Enterprise Value$147.21M
Total Cash (Recent Filing)$14.68M
Total Debt (Recent Filing)$5.28M
Price to Earnings (P/E)―
Beta1.05
Next Earnings
Mar 18, 2025EPS Estimate
-$0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding84,656,254
10 Day Avg. Volume363,096
30 Day Avg. Volume208,926
Standard Deviation0.18
R-Squared0.20
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)17.39
Price to Sales (P/S)6.60
Price to Cash Flow (P/CF)-12.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.20
Enterprise Value/Gross Profit9.91
Enterprise Value/Ebitda-8.19
Forecast
1Y Price Target
$4.33Price Target Upside91.59% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Stereotaxis News
PremiumCompany Announcements
Stereotaxis Reports Strong Q3 Growth in Robotics
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe revenue for Q3 exceeded expectations, driven by the recognition of three Genesis systems and strong performance in disposables.
Innovation And Market ExpansionThe new product portfolio enables increased per-procedure revenue potential (3-5x current per procedure potential), reduces system adoption friction, and establishes a platform technology.
Product ApprovalsMAGiC approval in Europe is expected soon, with positive interactions in the U.S., potentially unlocking significant revenue opportunities.
Bears Say
Financial PerformanceGross margin for the quarter was 45%, a significant decline from 52% last year, indicating potential challenges in maintaining profitability.
Future OutlookStereotaxis expects revenue to be greater than $14.0M in the second half of the year, implying a total revenue decline of 5% year-over-year for 2024, suggesting a cautious outlook for future growth.
RevenueRevenue totaled $4.5M, falling short of the Street's consensus estimate of $5.6M, highlighting potential concerns in meeting market expectations.
---
Ownership Overview
23.19% Insiders
6.50% Mutual Funds
4.58% Other Institutional Investors
59.84% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STXS FAQ
What was Stereotaxis’s price range in the past 12 months?
Stereotaxis lowest stock price was $1.40 and its highest was $3.29 in the past 12 months.
What is Stereotaxis’s market cap?
Currently, no data Available
When is Stereotaxis’s upcoming earnings report date?
Stereotaxis’s upcoming earnings report date is Mar 18, 2025 which is in 115 days.
How were Stereotaxis’s earnings last quarter?
Stereotaxis released its earnings results on Nov 11, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of -$0.052 by -$0.028.
Is Stereotaxis overvalued?
According to Wall Street analysts Stereotaxis’s price is currently Undervalued.
Does Stereotaxis pay dividends?
Stereotaxis does not currently pay dividends.
What is Stereotaxis’s EPS estimate?
Stereotaxis’s EPS estimate is -$0.07.
How many shares outstanding does Stereotaxis have?
Stereotaxis has 84,656,260 shares outstanding.
What happened to Stereotaxis’s price movement after its last earnings report?
Stereotaxis reported an EPS of -$0.08 in its last earnings report, missing expectations of -$0.052. Following the earnings report the stock price went up 22.162%.
Which hedge fund is a major shareholder of Stereotaxis?
Among the largest hedge funds holding Stereotaxis’s share is GMT Capital Corp. It holds Stereotaxis’s shares valued at 230K.
---
Stereotaxis Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$4.33 (91.59% Upside)
$4.33 (91.59% Upside)
Blogger Sentiment
Bullish
STXS Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 126.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $17.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 1.3%
Last 30 Days ▼ 1.1%
Last 30 Days ▼ 1.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.85%
12-Months-Change
Fundamentals
Return on Equity
-94.89%
Trailing 12-Months
Asset Growth
-25.46%
Trailing 12-Months
Company Description
Stereotaxis
Stereotaxis, Inc. engages in the design, manufacture, and market of robotic systems and instruments that electrophysiologists use for the treatment of abnormal heart rhythms known as cardiac arrhythmias. Its products include The Epoch Solution, Niobe Magnetic Navigation System, Vdrive Robotic Navigation System, and Odyssey Solution. The company was founded in June 1990 and is headquartered in St. Louis, MO.
---
STXS Earnings Call
Q3 2024
0:00 / 0:00
---
STXS Stock 12 Month Forecast
Average Price Target
$4.33
▲(91.59% Upside)
Technical Analysis
Best Analysts Covering STXS
1 Year
1 Year Success Rate
4/13 ratings generated profit
1 Year Average Return
-2.53%
reiterated a buy rating 11 days ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -2.53% per trade.
---